Pancreatic Cancer and its Treatment
Description
Pancreas is an organ in the human body that is located in the abdomen. It plays very vital and crucial role in transforming the food we eat into fuel for the human body’s cells. It has two main functions; exocrine function that supports in digestion and other is an endocrine function that controls blood sugar. Cancer begins when cells in the body start to grow out of control. As a matter of fact, cells in nearly any part of the body can become cancer and can spread to other parts of the body. It is very vital to know that if the cancer is an exocrine or endocrine because they have distinct risk, causes and they also have different signs and symptoms; they are diagnosed, treated different ways and have different viewpoint. The two major types of cancer in pancreas are exocrine pancreatic cancer and endocrine pancreatic tumors which are also called as neuroendocrine tumors.
Below list discusses various treatment
Files
Pancreatic cancer and its treatment.pdf
Files
(890.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:0142c871b108212b43365f5d347895eb
|
890.2 kB | Preview Download |
Additional details
Related works
References
- http://columbiasurgery.org/pancreas/pancreas-and-itsfunctions
- https://www.cancer.org/cancer/pancreatic-cancer/about/what-is-pancreatic-cancer.html
- Daniel Öhlund, Abram Handly-Santana, Giulia Biffi, et al. (2017) Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med Jem 214: 579-596.
- www.sciencedaily.com/releases/2017/02/170223124234.htm
- Magdolna Djurec, Osvaldo Graña, Albert Lee, et al. (2018) Saa3 is a key mediator of the protumorigenic properties of cancerassociated fibroblasts in pancreatic tumors. Proc Natl Acad Sci USA 115: E1147-E1156.
- www.sciencedaily.com/releases/2018/02/180201115728.htm
- Kenneth W Baumann, John M Baust, Kristi K Snyder, et al. (2017) Dual thermal ablation of pancreatic cancer cells as an improved combinatorial treatment strategy. Liver and Pancreatic Sciences2.
- www.sciencedaily.com/releases/2018/02/180226131424.htm
- Hadas Gibori, Shay Eliyahu, Adva Krivitsky, et al. (2018) Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer. Nat Commun 9: 16.
- www.sciencedaily.com/releases/2018/01/180102114228.htm
- Leore T Geller, Michal Barzily-Rokni, Tal Danino, et al. (2017) Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357: 1156-1160.
- www.sciencedaily.com/releases/2017/10/171005161127.htm
- Mitra M (2018) Editorial on Advanced Nanomedicine. Int J Nanotechnol Nanomed 2: 1-2.
- Bourzac K (2016) News Feature: Cancer nanomedicine,reengineered. Proc Natl Acad Sci U S A 113: 12600-12603.